Systemic and Peripheral Mechanisms of Cortical Stimulation-Induced Analgesia and Refractoriness in a Rat Model of Neuropathic Pain

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorASSIS, Danielle V.
dc.contributor.authorCAMPOS, Ana Carolina P.
dc.contributor.authorPASCHOA, Amanda F. N.
dc.contributor.authorSANTOS, Talita F.
dc.contributor.authorFONOFF, Erich T.
dc.contributor.authorPAGANO, Rosana L.
dc.date.accessioned2023-08-16T17:50:19Z
dc.date.available2023-08-16T17:50:19Z
dc.date.issued2023
dc.description.abstractEpidural motor cortex stimulation (MCS) is an effective treatment for refractory neuropathic pain; however, some individuals are unresponsive. In this study, we correlated the effectiveness of MCS and refractoriness with the expression of cytokines, neurotrophins, and nociceptive mediators in the dorsal root ganglion (DRG), sciatic nerve, and plasma of rats with sciatic neuropathy. MCS inhibited hyperalgesia and allodynia in two-thirds of the animals (responsive group), and one-third did not respond (refractory group). Chronic constriction injury (CCI) increased IL-1 fi in the nerve and DRG, inhibited IL-4, IL-10, and IL-17A in the nerve, decreased beta-endorphin, and enhanced substance P in the plasma, compared to the control. Responsive animals showed decreased NGF and increased IL-6 in the nerve, accompanied by restoration of local IL-10 and IL-17A and systemic beta-endorphin. Refractory animals showed increased TNF- alpha and decreased IFN gamma in the nerve, along with decreased TNF- alpha and IL-17A in the DRG, maintaining low levels of systemic beta-endorphin. Our findings suggest that the effectiveness of MCS depends on local control of inflammatory and neurotrophic changes, accompanied by recovery of the opioidergic system observed in neuropathic conditions. So, understanding the refractoriness to MCS may guide an improvement in the efficacy of the technique, thus benefiting patients with persistent neuropathic pain.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.description.sponsorshipCoordination for the Improvement of Higher Education Personnel (CAPES) [1409259]
dc.description.sponsorshipHospital Sirio-Libanes
dc.identifier.citationINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.24, n.9, article ID 7796, 18p, 2023
dc.identifier.doi10.3390/ijms24097796
dc.identifier.eissn1422-0067
dc.identifier.issn1661-6596
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/54723
dc.language.isoeng
dc.publisherMDPIeng
dc.relation.ispartofInternational Journal of Molecular Sciences
dc.rightsopenAccesseng
dc.rights.holderCopyright MDPIeng
dc.subjectmotor cortex stimulationeng
dc.subjectneuropathic paineng
dc.subjectsciatic nerveeng
dc.subjectinflammationeng
dc.subjectneurotrophinseng
dc.subjectsubstance Peng
dc.subjectbeta-endorphineng
dc.subject.othermotor cortex stimulationeng
dc.subject.otherdorsal-root gangliaeng
dc.subject.otherchronic constriction injuryeng
dc.subject.othersatellite glial-cellseng
dc.subject.otherbeta-endorphineng
dc.subject.othersciatic-nerveeng
dc.subject.otherdynamic regulationeng
dc.subject.othersensory neuronseng
dc.subject.othersubstance-peng
dc.subject.othertnf-alphaeng
dc.subject.wosBiochemistry & Molecular Biologyeng
dc.subject.wosChemistry, Multidisciplinaryeng
dc.titleSystemic and Peripheral Mechanisms of Cortical Stimulation-Induced Analgesia and Refractoriness in a Rat Model of Neuropathic Paineng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalASSIS, Danielle V.:Hosp Sirio Libanes, Lab Neurosci, BR-01308060 Sao Paulo, SP, Brazil
hcfmusp.author.externalCAMPOS, Ana Carolina P.:Hosp Sirio Libanes, Lab Neurosci, BR-01308060 Sao Paulo, SP, Brazil
hcfmusp.author.externalPASCHOA, Amanda F. N.:Hosp Sirio Libanes, Lab Neurosci, BR-01308060 Sao Paulo, SP, Brazil
hcfmusp.author.externalSANTOS, Talita F.:Hosp Sirio Libanes, Lab Neurosci, BR-01308060 Sao Paulo, SP, Brazil
hcfmusp.author.externalPAGANO, Rosana L.:Hosp Sirio Libanes, Lab Neurosci, BR-01308060 Sao Paulo, SP, Brazil
hcfmusp.citation.scopus2
hcfmusp.contributor.author-fmusphcERICH TALAMONI FONOFF
hcfmusp.description.articlenumber7796
hcfmusp.description.issue9
hcfmusp.description.volume24
hcfmusp.origemWOS
hcfmusp.origem.pubmed37175503
hcfmusp.origem.scopus2-s2.0-85159303719
hcfmusp.origem.wosWOS:000987309400001
hcfmusp.publisher.cityBASELeng
hcfmusp.publisher.countrySWITZERLANDeng
hcfmusp.relation.referenceAfif Afif, 2022, J Neurosurg Sci, V66, P560, DOI 10.23736/S0390-5616.20.04991-7eng
hcfmusp.relation.referenceAhmed MA, 2011, NEUROL RES, V33, P953, DOI 10.1179/1743132811Y.0000000045eng
hcfmusp.relation.referenceAhmed S, 2008, P NATL ACAD SCI USA, V105, P14692, DOI 10.1073/pnas.0802675105eng
hcfmusp.relation.referenceAustin PJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0318-4eng
hcfmusp.relation.referenceAustin PJ, 2013, NEUROPATHIC PAIN: CAUSES, MANAGEMENT, AND UNDERSTANDING, P77eng
hcfmusp.relation.referenceBach FW, 1997, DAN MED BULL, V44, P274eng
hcfmusp.relation.referenceBannwarth B, 2014, DRUGS, V74, P619, DOI 10.1007/s40265-014-0208-6eng
hcfmusp.relation.referenceBarker PA, 2020, J PAIN RES, V13, P1223, DOI 10.2147/JPR.S247472eng
hcfmusp.relation.referenceBENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6eng
hcfmusp.relation.referenceBoadas-Vaello P, 2016, SPINAL CORD, V54, P330, DOI 10.1038/sc.2015.225eng
hcfmusp.relation.referenceBobinski F, 2018, PAIN, V159, P437, DOI 10.1097/j.pain.0000000000001109eng
hcfmusp.relation.referenceLiu FY, 2012, BRAIN RES, V1427, P65, DOI 10.1016/j.brainres.2011.10.016eng
hcfmusp.relation.referenceMannion RJ, 2000, CLIN J PAIN, V16, pS144eng
hcfmusp.relation.referenceMantyh PW, 2011, ANESTHESIOLOGY, V115, P189, DOI 10.1097/ALN.0b013e31821b1ac5eng
hcfmusp.relation.referenceMartin SL, 2019, NEURAL REGEN RES, V14, P939, DOI 10.4103/1673-5374.250566eng
hcfmusp.relation.referenceMartucci C, 2008, PAIN, V137, P81, DOI 10.1016/j.pain.2007.08.017eng
hcfmusp.relation.referenceMcKelvey L, 2013, J NEUROCHEM, V124, P276, DOI 10.1111/jnc.12093eng
hcfmusp.relation.referenceMillan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3eng
hcfmusp.relation.referenceMilligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533eng
hcfmusp.relation.referenceMueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2eng
hcfmusp.relation.referenceMurray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010eng
hcfmusp.relation.referencePagano RL, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.08.003eng
hcfmusp.relation.referenceNarita M, 1998, JPN J PHARMACOL, V76, P233, DOI 10.1254/jjp.76.233eng
hcfmusp.relation.referenceNguyen JP, 2008, BRAIN STIMUL, V1, P89, DOI 10.1016/j.brs.2008.03.007eng
hcfmusp.relation.referenceNicolas N, 2018, WORLD NEUROSURG, V114, pE800, DOI 10.1016/j.wneu.2018.03.090eng
hcfmusp.relation.referencePagano RL, 2012, PAIN, V153, P2359, DOI 10.1016/j.pain.2012.08.002eng
hcfmusp.relation.referencePalmer MT, 2010, NAT IMMUNOL, V11, P36, DOI 10.1038/ni.1802eng
hcfmusp.relation.referencePannell M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0735-zeng
hcfmusp.relation.referencePathak NN, 2013, INFLAMMATION, V36, P1468, DOI 10.1007/s10753-013-9688-xeng
hcfmusp.relation.referencePerkins NM, 2000, NEUROSCIENCE, V101, P745, DOI 10.1016/S0306-4522(00)00396-1eng
hcfmusp.relation.referencePetraschka M, 2007, NEUROSCIENCE, V146, P1795, DOI 10.1016/j.neuroscience.2007.03.029eng
hcfmusp.relation.referencePeyron R, 2007, NEUROIMAGE, V34, P310, DOI 10.1016/j.neuroimage.2006.08.037eng
hcfmusp.relation.referenceRANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409eng
hcfmusp.relation.referenceSacerdote P, 2008, NEUROSCI LETT, V436, P210, DOI 10.1016/j.neulet.2008.03.023eng
hcfmusp.relation.referenceSacerdote P, 2013, J NEUROIMMUNE PHARM, V8, P202, DOI 10.1007/s11481-012-9428-2eng
hcfmusp.relation.referenceSilva GD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0216-1eng
hcfmusp.relation.referenceSaitoh Y, 2007, ACTA NEUROCHIR SUPPL, V97, P51eng
hcfmusp.relation.referenceSantos FM, 2018, BRAIN RES, V1687, P60, DOI 10.1016/j.brainres.2018.02.034eng
hcfmusp.relation.referenceSchnitzler A, 2000, J CLIN NEUROPHYSIOL, V17, P592, DOI 10.1097/00004691-200011000-00005eng
hcfmusp.relation.referenceShubayev VI, 2001, J NEUROIMMUNOL, V114, P48, DOI 10.1016/S0165-5728(00)00453-7eng
hcfmusp.relation.referenceSlotty PJ, 2015, STEREOT FUNCT NEUROS, V93, P199, DOI 10.1159/000375177eng
hcfmusp.relation.referenceStoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.xeng
hcfmusp.relation.referenceSun J, 2008, AM J PHYSIOL-CELL PH, V294, pC1586, DOI 10.1152/ajpcell.00129.2008eng
hcfmusp.relation.referenceTorrance N, 2013, PAIN, V154, P690, DOI 10.1016/j.pain.2012.12.022eng
hcfmusp.relation.referenceTreede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59eng
hcfmusp.relation.referenceVaculin S, 2008, EXP BRAIN RES, V185, P331, DOI 10.1007/s00221-007-1158-yeng
hcfmusp.relation.referencevan Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013eng
hcfmusp.relation.referenceVelasco F, 2008, J NEUROSURG, V108, P698, DOI 10.3171/JNS/2008/108/4/0698eng
hcfmusp.relation.referenceViisanen H, 2012, BRAIN RES BULL, V89, P133, DOI 10.1016/j.brainresbull.2012.08.002eng
hcfmusp.relation.referenceWatkins LR, 1999, ADV EXP MED BIOL, V461, P153eng
hcfmusp.relation.referenceViisanen H, 2010, NEUROSCI LETT, V476, P133, DOI 10.1016/j.neulet.2010.04.014eng
hcfmusp.relation.referenceVolkers R, 2020, NEUROMODULATION, V23, P436, DOI 10.1111/ner.13119eng
hcfmusp.relation.referenceWang H, 2014, NEUROLOGY, V83, P628, DOI 10.1212/WNL.0000000000000686eng
hcfmusp.relation.referenceWang JA, 2020, CHINESE MED J-PEKING, V133, P190, DOI 10.1097/CM9.0000000000000619eng
hcfmusp.relation.referenceWeaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557eng
hcfmusp.relation.referenceWhitehead KJ, 2010, BRAIN BEHAV IMMUN, V24, P569, DOI 10.1016/j.bbi.2009.12.007eng
hcfmusp.relation.referenceWoolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765eng
hcfmusp.relation.referenceWu G, 2002, J NEUROSCI, V22, P7746eng
hcfmusp.relation.referenceWu HY, 2018, BRAIN BEHAV IMMUN, V73, P504, DOI 10.1016/j.bbi.2018.06.015eng
hcfmusp.relation.referenceXing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368eng
hcfmusp.relation.referenceYamada K, 2003, J PHARMACOL SCI, V91, P267eng
hcfmusp.relation.referenceZhang RR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00286-0eng
hcfmusp.relation.referenceZhang Y, 2018, INFLAMMATION, V41, P569, DOI 10.1007/s10753-017-0713-3eng
hcfmusp.relation.referenceCampana WM, 2007, BRAIN BEHAV IMMUN, V21, P522, DOI 10.1016/j.bbi.2006.12.008eng
hcfmusp.relation.referenceZhang ZJ, 2017, CELL MOL LIFE SCI, V74, P3275, DOI 10.1007/s00018-017-2513-1eng
hcfmusp.relation.referenceZhi MJ, 2017, J PAIN RES, V10, DOI 10.2147/JPR.S139324eng
hcfmusp.relation.referenceZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4eng
hcfmusp.relation.referenceZizzo G, 2013, J IMMUNOL, V190, P5237, DOI 10.4049/jimmunol.1203017eng
hcfmusp.relation.referenceCHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9eng
hcfmusp.relation.referenceCharan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726eng
hcfmusp.relation.referenceCioato Stefania Giotti, 2021, BrJP, V4, P99, DOI 10.5935/2595-0118.20210031eng
hcfmusp.relation.referenceCohen SP, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7656eng
hcfmusp.relation.referenceColloca L, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.2eng
hcfmusp.relation.referenceCruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.xeng
hcfmusp.relation.referenceDailey AT, 1998, J NEUROSCI, V18, P6713eng
hcfmusp.relation.referenceDay YJ, 2014, PAIN, V155, P1293, DOI 10.1016/j.pain.2014.04.004eng
hcfmusp.relation.referencede Andrade EM, 2020, J NEUROSURG, V132, P239, DOI 10.3171/2018.7.JNS173239eng
hcfmusp.relation.referenceDelavallee M, 2014, ACTA NEUROCHIR, V156, P2289, DOI 10.1007/s00701-014-2240-4eng
hcfmusp.relation.referenceDubovy P, 2010, NEURON GLIA BIOL, V6, P73, DOI 10.1017/S1740925X10000074eng
hcfmusp.relation.referenceEl Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880eng
hcfmusp.relation.referenceFagundes-Pereyra WJ, 2010, ARQ NEURO-PSIQUIAT, V68, P923, DOI 10.1590/S0004-282X2010000600018eng
hcfmusp.relation.referenceFonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018eng
hcfmusp.relation.referenceFonoff ET, 2009, BEHAV BRAIN RES, V196, P63, DOI 10.1016/j.bbr.2008.07.027eng
hcfmusp.relation.referenceFontaine D, 2009, J NEUROSURG, V110, P251, DOI 10.3171/2008.6.17602eng
hcfmusp.relation.referenceGao YJ, 2003, BRAIN RES BULL, V61, P587, DOI 10.1016/S0361-9230(03)00215-6eng
hcfmusp.relation.referenceGao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016eng
hcfmusp.relation.referenceGarcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1eng
hcfmusp.relation.referenceGarcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016/j.neuroimage.2007.05.062eng
hcfmusp.relation.referenceGirach A, 2019, PAIN RES MANAG, V2019, DOI 10.1155/2019/2091960eng
hcfmusp.relation.referenceGrace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621eng
hcfmusp.relation.referenceGuerios SD, 2008, AM J PHYSIOL-REG I, V295, pR111, DOI 10.1152/ajpregu.00728.2007eng
hcfmusp.relation.referenceGuo CJ, 2002, J NEUROIMMUNOL, V131, P160, DOI 10.1016/S0165-5728(02)00277-1eng
hcfmusp.relation.referenceHamani C, 2021, BRAIN, V144, P2994, DOI 10.1093/brain/awab189eng
hcfmusp.relation.referenceHanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001eng
hcfmusp.relation.referenceHansson PT, 2009, EUR J PAIN, V13, P439, DOI 10.1016/j.ejpain.2009.02.008eng
hcfmusp.relation.referenceHartwig A C, 1991, Anesth Prog, V38, P75eng
hcfmusp.relation.referenceHegazy N, 2020, BASIC CLIN PHARMACOL, V127, P451, DOI 10.1111/bcpt.13453eng
hcfmusp.relation.referenceHenssen D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64177-zeng
hcfmusp.relation.referenceHolzer P, 1997, PHARMACOL THERAPEUT, V73, P219, DOI 10.1016/S0163-7258(96)00196-9eng
hcfmusp.relation.referenceHuang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677eng
hcfmusp.relation.referenceJi RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-Xeng
hcfmusp.relation.referenceJulius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019eng
hcfmusp.relation.referenceKatz N, 2011, PAIN, V152, P2248, DOI 10.1016/j.pain.2011.05.003eng
hcfmusp.relation.referenceKemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994eng
hcfmusp.relation.referenceKhan J, 2015, NEUROSCI LETT, V592, P99, DOI 10.1016/j.neulet.2015.03.001eng
hcfmusp.relation.referenceKilkenny C, 2010, J GENE MED, V12, P561, DOI [10.1002/jgm.1473, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]eng
hcfmusp.relation.referenceKim CF, 2011, J PAIN, V12, P370, DOI 10.1016/j.jpain.2010.08.003eng
hcfmusp.relation.referenceKim J, 2016, J NEUROSURG, V124, P866, DOI 10.3171/2015.1.JNS14891eng
hcfmusp.relation.referenceKleinschnitz C, 2006, EXP NEUROL, V200, P480, DOI 10.1016/j.expneurol.2006.03.014eng
hcfmusp.relation.referenceLa Rana G, 2008, NEUROPHARMACOLOGY, V54, P521, DOI 10.1016/j.neuropharm.2007.10.021eng
hcfmusp.relation.referenceLabuz D, 2010, BRAIN BEHAV IMMUN, V24, P1045, DOI 10.1016/j.bbi.2010.04.001eng
hcfmusp.relation.referenceLefaucheur JP, 2009, BRAIN, V132, P1463, DOI 10.1093/brain/awp035eng
hcfmusp.relation.referenceLima MC, 2008, NEUROLOGY, V70, P2329, DOI 10.1212/01.wnl.0000314649.38527.93eng
hcfmusp.relation.referenceLindborg JA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1222-5eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication4c02c3a0-da5e-4a38-ba96-49611c964133
relation.isAuthorOfPublication.latestForDiscovery4c02c3a0-da5e-4a38-ba96-49611c964133
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_ASSIS_Systemic_and_Peripheral_Mechanisms_of_Cortical_StimulationInduced_Analgesia_2023.PDF
Tamanho:
2.07 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)